김희성
#갑상선병리#유방병리
|
학력
1992. 서울의대 졸
1997. 서울대 의학석사
1999. 서울대 의학박사
1997. 서울대 의학석사
1999. 서울대 의학박사
경력
1998.03∼2000.02 : 삼성서울병원 임상강사
2000.10∼2004.02 : 국립암센터 선임연구원
2003.03∼2006.06 : 존스홉킨스대학 연구원
2008.08∼2010.02 : 강북삼성병원 임상부교수
2010.03∼2012.05 : 한일병원 주임과장
2012.06∼2013.02 : 가천대길병원 교수, 가천대학교 교수
2013.03∼현재, 중앙대학교병원 병리과 교수
2015.03-현재, 중앙대학교병원 병리과 진료과장
2000.10∼2004.02 : 국립암센터 선임연구원
2003.03∼2006.06 : 존스홉킨스대학 연구원
2008.08∼2010.02 : 강북삼성병원 임상부교수
2010.03∼2012.05 : 한일병원 주임과장
2012.06∼2013.02 : 가천대길병원 교수, 가천대학교 교수
2013.03∼현재, 중앙대학교병원 병리과 교수
2015.03-현재, 중앙대학교병원 병리과 진료과장
논문
* SCI and SCIE
1: Kim HS, Kim MA, Hodgson D, Harbron C, Wellings R, O'Connor MJ, Womack C, Yin X, Bang YJ, Im SA, Lee BL, Kim WH. Concordance of ATM (Ataxia Telangiectasia Mutated) Immunohistochemistry between Biopsy or Metastatic Tumor Samples and Primary Tumors in Gastric Cancer Patients. Pathobiology. 2013;80(3):127-37. doi: 10.1159/000346034. Epub 2013 Jan 15. PubMed PMID: 23328638.
2: Moon HG, Yi JK, Kim HS, Lee HY, Lee KM, Yi M, Ahn S, Shin HC, Ju JH, Shin I, Han W, Noh DY. Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer. BMC Cancer. 2012 Dec 10;12:585. doi: 10.1186/1471-2407-12-585. PubMed PMID: 23216670; PubMed Central PMCID: PMC3523086.
3: Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer. Anticancer Res. 2012 Aug;32(8):3169-75. PubMed PMID: 22843889.
4: Hwang KT, Woo JW, Shin HC, Kim HS, Ahn SK, Moon HG, Han W, Park IA, Noh DY. Prognostic influence of BCL2 expression in breast cancer. Int J Cancer. 2012 Oct 1;131(7):E1109-19. doi: 10.1002/ijc.27539. Epub 2012 Apr 4. PubMed PMID:22418857.
5: Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer. 2011 Dec;14(4):262-8. doi: 10.4048/jbc.2011.14.4.262. Epub 2011 Dec 27. PubMed PMID: 22323911; PubMed Central PMCID: PMC3268921.
6: Yang WS, Moon HG, Kim HS, Choi EJ, Yu MH, Noh DY, Lee C. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer. J Proteome Res. 2012 Feb 3;11(2):1078-88. doi: 10.1021/pr2008187. Epub 2011 Dec 6. PubMed PMID:22074005.
7: Kim HS, Lee HS, Kim WH. Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors. Cancer Res Treat. 2011 Sep;43(3):181-8. doi: 10.4143/crt.2011.43.3.181. Epub 2011 Sep 30. PubMed PMID: 22022296; PubMed Central PMCID: PMC3192880.
8: Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, Lee DS. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res. 2011 Oct 3;13(5):R96. doi:10.1186/bcr3034. PubMed PMID: 21967801; PubMed Central PMCID: PMC3262209.
9: Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol. 2011 Dec;5(6):538-44. doi: 10.1016/j.molonc.2011.08.002. Epub 2011 Aug 8. PubMed PMID: 21925980.
10: Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY. COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res Treat. 2012 Feb;132(1):51-9. doi: 10.1007/s10549-011-1521-3. Epub 2011 Apr 28. PubMed PMID: 21533532.
11: Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, Green JE. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One. 2011 Feb 18;6(2):e16694. doi: 10.1371/journal.pone.0016694. PubMed PMID: 21364753; PubMed Central PMCID: PMC3041770.
12: Yom CK, Noh DY, Kim WH, Kim HS. Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer. Breast Cancer Res Treat. 2011 Aug;128(3):647-55. doi: 10.1007/s10549-010-1150-2. Epub 2010 Sep 3. PubMed PMID: 20814816.
13: Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res. 2010 Aug 6;9(8):4123-30. doi: 10.1021/pr100302b. Erratum in: J Proteome Res. 2011 Jan 7;10(1):361. PubMed PMID: 20557134; PubMed Central PMCID: PMC3441055.
14: Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol. 2010 Sep;21(3):149-53. doi: 10.1007/s12022-010-9124-9. PubMed PMID: 20506003.
15: Kim JH, Cho YH, Park YL, Sohn JH, Kim HS. Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer. Oncol Rep. 2010 Apr;23(4):989-95. PubMed PMID:20204283.
16: Yom CK, Woo HY, Min SY, Kang SY, Kim HS. Clusterin overexpression and relapse-free survival in breast cancer. Anticancer Res. 2009 Oct;29(10):3909-12. PubMed PMID: 19846927.
17: Kim HS. Leptin and leptin receptor expression in breast cancer. Cancer Res Treat. 2009 Sep;41(3):155-63. doi: 10.4143/crt.2009.41.3.155. Epub 2009 Sep 28. PubMed PMID: 19809565; PubMed Central PMCID: PMC2757661.
18: Kim HS, Yom CK, Kim HJ, Lee JW, Sohn JH, Kim JH, Park YL, Ahn SH. Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy. Breast Cancer Res Treat. 2010 Jun;121(3):777-88. doi: 10.1007/s10549-009-0560-5. Epub 2009 Oct 6. PubMed PMID: 19806450.
19: Kim HK, Choi IJ, Kim HS, Kim JH, Kim E, Park IS, Chun JH, Kim IH, Kim IJ, Kang HC, Park JH, Bae JM, Lee JS, Park JG. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun. 2004 Apr 9;316(3):781-9. PubMed PMID: 15033468.
1: Kim HS, Kim MA, Hodgson D, Harbron C, Wellings R, O'Connor MJ, Womack C, Yin X, Bang YJ, Im SA, Lee BL, Kim WH. Concordance of ATM (Ataxia Telangiectasia Mutated) Immunohistochemistry between Biopsy or Metastatic Tumor Samples and Primary Tumors in Gastric Cancer Patients. Pathobiology. 2013;80(3):127-37. doi: 10.1159/000346034. Epub 2013 Jan 15. PubMed PMID: 23328638.
2: Moon HG, Yi JK, Kim HS, Lee HY, Lee KM, Yi M, Ahn S, Shin HC, Ju JH, Shin I, Han W, Noh DY. Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer. BMC Cancer. 2012 Dec 10;12:585. doi: 10.1186/1471-2407-12-585. PubMed PMID: 23216670; PubMed Central PMCID: PMC3523086.
3: Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer. Anticancer Res. 2012 Aug;32(8):3169-75. PubMed PMID: 22843889.
4: Hwang KT, Woo JW, Shin HC, Kim HS, Ahn SK, Moon HG, Han W, Park IA, Noh DY. Prognostic influence of BCL2 expression in breast cancer. Int J Cancer. 2012 Oct 1;131(7):E1109-19. doi: 10.1002/ijc.27539. Epub 2012 Apr 4. PubMed PMID:22418857.
5: Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI. Clinical significance of annexin A1 expression in breast cancer. J Breast Cancer. 2011 Dec;14(4):262-8. doi: 10.4048/jbc.2011.14.4.262. Epub 2011 Dec 27. PubMed PMID: 22323911; PubMed Central PMCID: PMC3268921.
6: Yang WS, Moon HG, Kim HS, Choi EJ, Yu MH, Noh DY, Lee C. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer. J Proteome Res. 2012 Feb 3;11(2):1078-88. doi: 10.1021/pr2008187. Epub 2011 Dec 6. PubMed PMID:22074005.
7: Kim HS, Lee HS, Kim WH. Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors. Cancer Res Treat. 2011 Sep;43(3):181-8. doi: 10.4143/crt.2011.43.3.181. Epub 2011 Sep 30. PubMed PMID: 22022296; PubMed Central PMCID: PMC3192880.
8: Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, Lee DS. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res. 2011 Oct 3;13(5):R96. doi:10.1186/bcr3034. PubMed PMID: 21967801; PubMed Central PMCID: PMC3262209.
9: Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol. 2011 Dec;5(6):538-44. doi: 10.1016/j.molonc.2011.08.002. Epub 2011 Aug 8. PubMed PMID: 21925980.
10: Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY. COX2 overexpression is a prognostic marker for Stage III breast cancer. Breast Cancer Res Treat. 2012 Feb;132(1):51-9. doi: 10.1007/s10549-011-1521-3. Epub 2011 Apr 28. PubMed PMID: 21533532.
11: Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, Green JE. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One. 2011 Feb 18;6(2):e16694. doi: 10.1371/journal.pone.0016694. PubMed PMID: 21364753; PubMed Central PMCID: PMC3041770.
12: Yom CK, Noh DY, Kim WH, Kim HS. Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer. Breast Cancer Res Treat. 2011 Aug;128(3):647-55. doi: 10.1007/s10549-010-1150-2. Epub 2010 Sep 3. PubMed PMID: 20814816.
13: Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res. 2010 Aug 6;9(8):4123-30. doi: 10.1021/pr100302b. Erratum in: J Proteome Res. 2011 Jan 7;10(1):361. PubMed PMID: 20557134; PubMed Central PMCID: PMC3441055.
14: Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol. 2010 Sep;21(3):149-53. doi: 10.1007/s12022-010-9124-9. PubMed PMID: 20506003.
15: Kim JH, Cho YH, Park YL, Sohn JH, Kim HS. Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer. Oncol Rep. 2010 Apr;23(4):989-95. PubMed PMID:20204283.
16: Yom CK, Woo HY, Min SY, Kang SY, Kim HS. Clusterin overexpression and relapse-free survival in breast cancer. Anticancer Res. 2009 Oct;29(10):3909-12. PubMed PMID: 19846927.
17: Kim HS. Leptin and leptin receptor expression in breast cancer. Cancer Res Treat. 2009 Sep;41(3):155-63. doi: 10.4143/crt.2009.41.3.155. Epub 2009 Sep 28. PubMed PMID: 19809565; PubMed Central PMCID: PMC2757661.
18: Kim HS, Yom CK, Kim HJ, Lee JW, Sohn JH, Kim JH, Park YL, Ahn SH. Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy. Breast Cancer Res Treat. 2010 Jun;121(3):777-88. doi: 10.1007/s10549-009-0560-5. Epub 2009 Oct 6. PubMed PMID: 19806450.
19: Kim HK, Choi IJ, Kim HS, Kim JH, Kim E, Park IS, Chun JH, Kim IH, Kim IJ, Kang HC, Park JH, Bae JM, Lee JS, Park JG. DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun. 2004 Apr 9;316(3):781-9. PubMed PMID: 15033468.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.